Ochoa Sangrador C, Rodríguez-Salinas Pérez E. Vaccinating pregnant women can prevent respiratory syncytial virus bronchiolitis in infants . Rev Pediatr Aten Primaria. 2024;26:93-6.

Montesdeoca Melián A, Rivero Calle I. Comment by the Advisory Committee on Vaccines of the Spanish Association of Paediatrics on Evidences in Paediatrics about nirsevimab . Rev Pediatr Aten Primaria. 2023;25:309-12.

del Castillo Velilla I, Carvajal Alonso-Barajas ME, González Marín MA, Arrabal Vela MA. Respiratory syncytial virus: not only bronchiolitis in infants. Rev Pediatr Aten Primaria. 2018;20:379-82.

Pérez Cid L, San José Valiente B, Quintero Calcaño V, Díaz López G, Mesa Guzmán J, Cañete Díaz A, et al. Severe bronchiolitis in infants under six months is a major risk factor for recurrent wheezing. Rev Pediatr Aten Primaria. 2013;15:229-37.

Gómez Carrasco JÁ, Merino Villeneuve I, Herbozo Nory C, González Santiago P, López Lois G, García de Frías E. Analysis of the children admitted to a Pediatric department. Rev Pediatr Aten Primaria. 2009;11:207-18.

González de Dios J, Ochoa Sangrador C, Balaguer Santamaría JA. Respiratory syncytial virus prophylaxis with monoclonal antibodies (palivizumab) in congenital cardiopathies: critical review of efficacy, effectiveness, efficiency and safety. Rev Pediatr Aten Primaria. 2007;9:71-100.

Ortiz Movilla R, Álvarez Fernández B, Martínez Bernat L, Iglesias González-Nicolás E, Muro Brussi M. Epidemiology and prevention of respiratory syncytial virus. Rev Pediatr Aten Primaria. 2006;8:627-40.